C2ORF15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.073000E-01
Normal-vs-Stage2
6.918600E-01
Normal-vs-Stage3
1.437630E-01
Normal-vs-Stage4
7.942800E-01
Stage1-vs-Stage2
1.879170E-03
Stage1-vs-Stage3
5.322000E-03
Stage1-vs-Stage4
6.542100E-02
Stage2-vs-Stage3
6.163600E-02
Stage2-vs-Stage4
9.283400E-01
Stage3-vs-Stage4
6.132300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.169800E-01
Normal-vs-AfricanAmerican
7.238000E-01
Normal-vs-Asian
5.627200E-01
Caucasian-vs-AfricanAmerican
7.377400E-01
Caucasian-vs-Asian
4.169800E-01
AfricanAmerican-vs-Asian
7.636600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.883400E-01
Normal-vs-Female
8.385600E-01
Male-vs-Female
7.506400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.416400E-01
Normal-vs-Age(41-60Yrs)
9.790400E-01
Normal-vs-Age(61-80Yrs)
7.587400E-01
Normal-vs-Age(81-100Yrs)
6.205200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.309610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.507700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.480400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.484400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.037800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.741800E-01
Normal-vs-Daily Drinker
8.128000E-01
Normal-vs-Weekly Drinker
6.921600E-01
Normal-vs-Occasional Drinker
9.731800E-01
Normal-vs-Social Drinker
8.129400E-01
Non Drinker-vs-Daily Drinker
7.152000E-01
Non Drinker-vs-Weekly Drinker
7.845400E-01
Non Drinker-vs-Occasional Drinker
4.838800E-01
Non Drinker-vs-Social Drinker
2.950000E-01
Daily Drinker-vs-Weekly Drinker
6.169600E-01
Daily Drinker-vs-Occasional Drinker
7.253200E-01
Daily Drinker-vs-Social Drinker
4.174600E-01
Weekly Drinker-vs-Occasional Drinker
4.867600E-01
Weekly Drinker-vs-Social Drinker
3.046000E-01
Occasional Drinker-vs-Social Drinker
5.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.485800E-02
Normal-vs-Grade 2
8.143600E-03
Normal-vs-Grade 3
9.601500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.726400E-02
Grade 1-vs-Grade 3
2.511200E-01
Grade 1-vs-Grade 4
5.485800E-02
Grade 2-vs-Grade 3
3.458600E-01
Grade 2-vs-Grade 4
8.143600E-03
Grade 3-vs-Grade 4
9.601500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.679400E-01
Normal-vs-NonDiabetic
9.946400E-01
Diabetic-vs-NonDiabetic
8.443600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.810000E-01
Normal-vs-NoPancreatitis
8.748200E-01
Pancreatitis-vs-NoPancreatitis
8.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.755400E-01
Normal-vs-N1
7.454600E-01
N0-vs-N1
3.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.400200E-01
Normal-vs-TP53-NonMutant
7.388800E-01
TP53-Mutant-vs-TP53-NonMutant
2.771600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
